Works matching IS 22113428 AND DT 2021 AND VI 44 AND IP 2


Results: 15
    1
    2
    3
    4
    5
    6

    Clinical perspectives of BET inhibition in ovarian cancer.

    Published in:
    Cellular Oncology (2211-3428), 2021, v. 44, n. 2, p. 237, doi. 10.1007/s13402-020-00578-6
    By:
    • Andrikopoulou, Angeliki;
    • Liontos, Michalis;
    • Koutsoukos, Konstantinos;
    • Dimopoulos, Meletios-Athanasios;
    • Zagouri, Flora
    Publication type:
    Article
    7
    8
    9
    10

    AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.

    Published in:
    Cellular Oncology (2211-3428), 2021, v. 44, n. 2, p. 357, doi. 10.1007/s13402-020-00571-z
    By:
    • Peraldo-Neia, Caterina;
    • Ostano, Paola;
    • Mello-Grand, Maurizia;
    • Guana, Francesca;
    • Gregnanin, Ilaria;
    • Boschi, Donatella;
    • Oliaro-Bosso, Simonetta;
    • Pippione, Agnese Chiara;
    • Carenzo, Andrea;
    • De Cecco, Loris;
    • Cavalieri, Stefano;
    • Micali, Arianna;
    • Perrone, Federica;
    • Averono, Gianluca;
    • Bagnasacco, Paolo;
    • Dosdegani, Riccardo;
    • Masini, Laura;
    • Krengli, Marco;
    • Aluffi-Valletti, Paolo;
    • Valente, Guido
    Publication type:
    Article
    11
    12
    13
    14
    15